Deficient Signaling via Alk2 (Acvr1) Leads to Bicuspid Aortic Valve Development by Thomas, Penny S. et al.
Deficient Signaling via Alk2 (Acvr1) Leads to Bicuspid
Aortic Valve Development
Penny S. Thomas
1, Somyoth Sridurongrit
1¤, Pilar Ruiz-Lozano
2, Vesa Kaartinen
1*
1Department of Biologic and Materials Sciences, University of Michigan, Ann Arbor, Michigan, United States of America, 2Department of Pediatrics, Stanford University
School of Medicine, Stanford, California, United States of America
Abstract
Bicuspid aortic valve (BAV) is the most common congenital cardiac anomaly in humans. Despite recent advances, the
molecular basis of BAV development is poorly understood. Previously it has been shown that mutations in the Notch1 gene
lead to BAV and valve calcification both in human and mice, and mice deficient in Gata5 or its downstream target Nos3 have
been shown to display BAVs. Here we show that tissue-specific deletion of the gene encoding Activin Receptor Type I (Alk2
or Acvr1) in the cushion mesenchyme results in formation of aortic valve defects including BAV. These defects are largely
due to a failure of normal development of the embryonic aortic valve leaflet precursor cushions in the outflow tract
resulting in either a fused right- and non-coronary leaflet, or the presence of only a very small, rudimentary non-coronary
leaflet. The surviving adult mutant mice display aortic stenosis with high frequency and occasional aortic valve insufficiency.
The thickened aortic valve leaflets in such animals do not show changes in Bmp signaling activity, while Map kinase
pathways are activated. Although dysfunction correlated with some pro-osteogenic differences in gene expression, neither
calcification nor inflammation were detected in aortic valves of Alk2 mutants with stenosis. We conclude that signaling via
Alk2 is required for appropriate aortic valve development in utero, and that defects in this process lead to indirect
secondary complications later in life.
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Introduction
Bicuspid aortic valve (BAV) is the most common cardiac
malformation affecting 1–2% people worldwide [1–3]. While
those with BAV often remain asymptomatic for years, almost all
will eventually require surgical intervention [3]. The molecular
mechanisms underlying BAV formation are still poorly elucidated.
In humans, mutations in the NOTCH1 gene have been shown to
lead to BAV [4]. An increased incidence of BAV has also been
found in in mice deficient in the transcription factor Nkx2-5 [5],
endothelium-specific nitric oxide synthase Nos3 [6] and, most
recently, transcription factor Gata5, which is proposed to
positively regulate Nos3 expression and affect the Notch signaling
pathway [7].
An initial key event in cardiac valve development is formation of
endocardial cushions [8], which starts with a regional increase of
cardiac jelly, a hyaluronic acid-rich extracellular matrix (ECM),
between the myocardial and endocardial cell layers at the sites of
the future atrio-ventricular junction (AVJ) and outflow tract (OFT)
[9]. This is followed by transformation of a subset of the overlying
endocardial cells to mesenchymal cells (EMT) [10] which migrate
into the underlying ECM to populate the cushions. In the OFT,
the proximal cushion mesenchyme is so derived from the
endocardium, and much of the more distal cushion mesenchyme
is of cranial neural crest origin [11]. Before OFT septation, four
ridge-like cushions spiral around the internal circumference of the
OFT lumen; two larger (septal and parietal) and, between them,
two smaller (anterior and posterior intercalated). The two larger
cushions fuse across the midline of the OFT lumen, creating
separate outlet lumens connecting the left and right ventricles to
their respective arterial valves (aortic and pulmonary). Around
each of these, further cushion growth from each of the larger
(fused) cushions and the intercalated cushion forms the three
arterial valve leaflet precursors for each truncal valve (aortic and
pulmonary) [12]. After further development, the right and left
coronary arteries connect to the aortic valve sinuses in character-
istic positions immediately downstream of the right and left
coronary leaflet precursors respectively [13]. The remaining
leaflet, the ‘non-coronary’, is the one arising from the intercalated
cushion position. These cushions undergo characteristic morpho-
genesis to form three flexible apposing leaflets and adjacent sinuses
[14]. Normal function of these leaflets requires that they are
sufficiently apart during ventricular systole, and appose each other
to prevent backflow during diastole, otherwise aortic stenosis and
insufficiency respectively will result. A critical distinctive extracel-
lular matrix arrangement is required to maintain these properties
throughout life [15–17]. With time, or if the leaflets are abnormal
in shape or number, the leaflets are more likely to fail mechanically
and develop abnormal structure and function [18,19]. From
examination of human examples, a reduction in effective leaflet
number to form a bicuspid (two leaflet, or bifoliate) aortic valve
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including before birth at the ‘cushion’ stage, rather than the
presence of only two leaflet cushions per arterial valve at the
outset.
In humans, anatomical classification of BAVs indicates all
combinations of leaflet fusion can be found, the two most common
being right- with non-coronary leaflets (R-N), and right with left-
coronary leaflets (R-L) [3,20]. A recent comparative study of the
Nos3 knockout mouse (R-L) and inbred Syrian hamster (R-L)
bicuspid models demonstrates that the etiologies of these
phenotypes are different [21]. Given that patients with R-N
leaflet fusion develop different clinical phenotypes from those of
patients with R-L leaflet fusion, mechanistic understanding of
aortic valve development at both morphological and molecular
levels is of critical importance [22,23].
Bmp signaling has been shown to play a critical role during
cardiac valve development. Several studies have shown that Bmp2
is able to induce EMT both in vitro and in vivo [24,25]. Both Bmp
type I receptor Alk3 (Bmpr1a) and Activin type I receptor (Alk2;
Acvr1) are expressed in the endocardium, and epithelium-specific
deletion of these receptors leads to EMT defects in both OFT and
AV cushions [25–28]. The importance of Alk2-mediated signaling
in human cardiac disease is highlighted by recent studies, which
demonstrate that mutations in the ALK2 gene are also responsible
for cardiac defects in humans [29,30].
While the role of Alk2 in endothelial EMT is well-established
[26], very little is known about Alk2-mediated Bmp signaling in
subsequent stages of valve development. In this study we examined
the role of Alk2 in cardiac valve development by deleting Alk2
function in the cushion mesenchyme after EMT using the Gata5-
Cre driver line. Most of the resulting Alk2 mutant mice developed
aortic valve defects characterized as ‘functional’ BAV as they
consisted of only two, apposed, morphologically functional aortic
leaflets (or their precursors), even if other structures were present,
prior to birth. A subset of mutant mice that survived to adulthood
developed aortic insufficiency and/or stenosis associated with
some markers of a pro-osteogenic phenotype: attenuated Sox9
expression, increased osteopontin (Spp1) expression and activated
Erk1/2 but did not develop calcification. These results suggest that
signaling via Alk2 is required for normal aortic valve development
Figure 1. The Gata5-Cre transgene induces recombination in the endocardial cushion mesenchyme after EMT. Comparison of areas of
Gata5-Cre (A), Tie2-Cre (B) and Wnt1-Cre (C) recombination (blue) in OFT region (arrowhead) at E11.5 (wholemount R26R-driven bgal stain, viewed
from the left side, distal OFT to the right). bgal staining of sagittal sections at E10 (D) and at E11 (E) shows extensive Gata5-Cre-induced recombination
in OFT cushion mesenchyme by E11 (arrow), but not in endocardium (arrowhead). Comparison of Gata5-Cre (F, H and J) and Tie2-Cre (G, I and K)
recombination patterns (R26R-driven b-gal stain in blue) at three levels of the OFT, from proximal (J, K) to distal (F, G). Tie2-Cre (arrowheads, G, I) but
not Gata5-Cre (arrowheads F, H) drives recombination (blue) in endocardium; recombined mesenchymal cells (blue) in both lines (arrows, J, K) only in
proximal OFT. Comparison of Gata5-Cre and (L, N and P) Tie2-Cre (M, O and Q) recombination at AV junction: sagittal sections (L–O) at E10 (L, M) and
E11 (N, O) and transverse sections at E11 (P, Q). At E10 (L, M) endocardium (arrowhead) recombined (blue) by Tie2-Cre but not Gata5-Cre. At E11 (N–P)
AV mesenchymal cells (arrows) recombined (blue) by both Tie2-Cre and Gata5-Cre. R, In situ hybridization for Alk2 RNA showing expression (blue) in
OFT cushion mesenchyme (black arrows) and endocardium (arrowhead) at E11.5. LV, left ventricle; RV, right ventricle; OFT myo, OFT myocardium; AV,
AV cushion; AVJ, atrioventricular junction.
doi:10.1371/journal.pone.0035539.g001
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aortic insufficiency and/or stenosis and formation of a bicuspid
aortic valve phenotype commonly found in humans.
Results
Gata5-Cre drives an efficient recombination in the
endocardial cushion mesenchyme
The Gata5-Cre transgenic mouse line was originally designed as
an epicardium-specific driver line [31]. When analyzing recom-
bination patterns in these mice, we noticed that in addition to
epicardial cells and occasional myocardial cells, efficient recom-
bination could also be detected in endocardial cushion mesen-
chyme at both the OFT and AV junction at E11 (Figure 1). Unlike
the Wnt1-Cre and Tie2-Cre drivers, which induce recombination in
neural crest (NC) cells including the distal cushion mesenchyme,
and in endothelial cells and endocardium-derived proximal
cushion mesenchyme, respectively, Gata5-Cre-induced recombina-
tion occurred in mesenchyme the entire length of the OFT
cushions (Figure 1A–C). Recombination occurred soon after
mesenchyme cell formation or arrival (E11) in OFT and AV
cushions (Figure 1D–Q), but did not start in the overlying
endocardial cells until E12 (data not shown). We have previously
shown that, in addition to endocardial cells, Alk2 is strongly
expressed in the newly formed AV cushion mesenchyme [26].
Similarly, Alk2 is expressed in the OFT endocardium, as well as in
the NC-derived and endocardium-derived OFT cushion mesen-
chyme (Figure 1R).
Deletion of Alk2 in the post-EMT cushion mesenchyme
leads to valve and septal defects
To investigate roles for Alk2 in mesenchyme during valve
formation and maturation following EMT we deleted Alk2
function there using the Gata5-Cre driver line. A role in these
events for Alk2 expressed in other cell types in which Gata5-Cre-
induced recombination occurs (epicardium and patches of
differentiated myocardium) can be largely ignored as key
epicardium-dependent events were not affected when Alk2
function was deleted using the epicardial driver Tbx18-Cre (Figure
S1) or in the working myocardium [26].
At E11, OFT cushions in Alk2/Gata5-Cre mutants contained
numerous mesenchymal cells arranged in characteristic cushions
indistinguishable from those of Alk2/Gata5-Cre
2 controls despite
efficient recombination of the Alk2 gene as shown by the RT-PCR
assay using primers flanking exon 7 which is deleted in the
recombined allele [32] (Figure 2), and reduced downstream
signaling: a 50% reduction in Smad1,5,8 phosphorylation levels in
OFT cushion tissues harvested at E12.
By E14, Alk2/Gata5-Cre mutants had developed abnormal
cardiac phenotypes that showed high penetrance (Table 1). Seven
out of nine mutant embryos displayed essentially bicuspid (two
leaflet or bifoliate) aortic valves (BAVs) and/or perimembranous
ventricular septal defects (VSDs) (Table 1). In all controls
(Alk2
FXWT/Gata5-Cre
2) examined, fusion events to complete the
ventricular septum had occurred and the aortic valves had three
normal leaflets. No abnormal pulmonary valves, or defects in great
artery development were found in controls or mutants.
Detailed histological examination (representative examples
shown in Figure 3) were undertaken to define the morphology of
the mutant aortic valves at E14 and E17, and to enable
comparison with established rodent models of BAV [22] and
bicuspid human aortic valves [33]. The abnormal valve phenotype
was manifest as two large leaflet cushions and one much smaller,
less developed, leaflet cushion in the non-coronary position at E14
(Figure 3F), and functionally bicuspid aortic valves (i.e. morpho-
logical evidence that the function of preventing backflow was
being performed by only two, large apposing leaflets) at E17
(Figure 3K, L). By this later stage, a spectrum of abnormal right
and non-coronary leaflet development was found, ranging from
apparent fusion (as implied by the presence of a raphe, for
example: Figure 3N) to the presence of a small, poorly developed
cushion in the non-coronary position but slightly proximal to the
level of apposition of the two, functional, leaflets (Figure 3O, R).
Position and number of coronary orifices was normal in all
mutants examined (Figure 3A, B, G–I) and these and the relative
position of the pulmonary valve enabled the position of the
abnormal/‘missing’ valve cushion to be consistently identified.
Thus the bicuspid phenotype here more closely resembled the
mouse BAV models in which Gata5 or Nos3 are deficient, as the
hamster model involves common or fused right- and left-, and not
non-coronary, leaflets. It was also notable that, even in E18 control
valves, the right and non-coronary leaflet cushions had not yet
become separated more proximally to form an ‘interleaflet
triangle’, unlike the other leaflet pairs (Figure 3M,P). This
maintained proximity may contribute to or reflect the mechanism
by which this class of bicuspid valve persists into postnatal life.
45% of Alk2/Gata5-Cre mutants survived to 3 weeks postnatally
(n=53). In surviving postnatal mutants at two months and older, 3
of 22 examined had a functionally biscuspid aortic valve
(Figure 3T) of the same pattern as identified prenatally. Overall,
a spectrum of aortic valve phenotypes was present, including
tricuspid, tricuspid with a smaller non-coronary leaflet, and
functionally bicuspid with a very small third sinus and thickened
non-coronary leaflet only revealed by sectioning (data not shown).
Valves identified as functionally stenotic had irregularly thickened
leaflets on sectioning whether bi or tri-cuspid (see the results below
and data not shown).
The VSD phenotype found in 7 of 9 mutant hearts at E14 was
detectable in only 2 out of 6 mutants at E18, suggesting earlier
VSDs likely represented a subtle delay in fusion that could still
could be ‘rescued’ during the last four gestational days. Besides the
aortic valves, Alk2/Gata5-Cre mutants also displayed abnormally
short and muscular right atrioventricular valve leaflets at E18
when compared to corresponding control littermates, while the left
atriocentricular valves appeared grossly normal (Figure 4).
Cushion mesenchyme deficient in Alk2 showed reduced
cell proliferation and altered gene expression
Maturation of cushion morphology is tightly coordinated with
growth by cell proliferation and remodeling by programmed cell
death. A 20–25% reduction in mesenchymal cell proliferation has
previously been reported in Gata5-deficient BAV model mice [7],
so we looked for differences in these processes between Alk2/
Gata5-Cre mutants and controls. At E11 and E12, a period of rapid
cushion growth, Alk2/Gata5-Cre mutant OFT cushions showed a
40% reduction in proliferation when compared to controls
(Figure 5), but no detectable changes in apoptosis at E12 (data
not shown).
Transcription factors and ECM components have been
proposed to contribute to cushion morphogenesis. Sox9 and
Tbx20 have been reported as positive regulators of cushion
mesenchyme proliferation and Bmp2, a possible ligand for Alk2,
shown to induce Tbx20 expression indirectly in vitro [23,24,25] so
we examined their expression by in situ hybridization (ISH). There
was no difference in staining pattern in cushion endocardium for
either RNA between control and mutant, including areas of higher
expression (Figure 6I,J). In cushion mesenchymal cells, expression
of both genes was easily detected in both control and mutant
Alk2 in Aortic Valve Development
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function. A more detailed examination of the relative stain
intensities within the same section showed variation amongst
adjacent mesenchyme cells in the same cushion. While some of
this may be attributable to cells cut by sectioning there are areas
where all the cells appear less stained (for Tbx20 in mutant OFT
cushion: Figure 6H; the same regional pattern was obtained on a
sister section (data not shown).
It was recently shown that proteolytic cleavage of versican, a
large extracellular matrix proteoglycan, is an important step in the
regulation of late embryonic valve development and that a failure
in this process leads to formation of thick myxomatous valves [34].
While versican protein levels were comparable between Alk2/
Gata5-Cre mutants and controls (Figure 6K–L), immunostaining
also detected less cleaved versican in mutant AV, but not OFT,
cushions (Figure 7). In addition, immunostaining for the extra-
cellular matrix glycoprotein, tenascin-C, expression of which has
been shown to be associated with areas undergoing major
structural changes during OFT morphogenesis in the chick [35],
was reduced in both OFT cushions and in developing AV valves
(Figure 6Q–T). These results imply that Alk2-mediated signaling is
involved in regulation of extracellular matrix deposition and/or
remodeling. However, the lack of differences in anti-DPEAAE-
positive immunostaining between Alk2 mutant and control OFT
cushions argues that Adamts-induced versican cleavage here is not
involved in development of the aortic valve phenotype observed in
Alk2/Gata5-Cre mutants.
Despite a reduced proliferation rate in OFT mesenchyme at
E11 and 12, sufficient mesenchymal cells were present in time for
both AV and OFT septation to occur in mutants, However, other
cushion-related abnormalities occurred subsequently, so subtle
defects in expression and processing of molecules such as those
discussed above might still leave Alk2/Gata5-Cre mutants more
vulnerable to morphological abnormalities and environmental or
epigenetic effects.
Expression of key regulators associated with BAVs or
valve maturation
It has previously been shown that defective function of Notch1,
Gata5 or Nos3 leads to BAV development, and that, where
Figure 2. The overall cushion morphology is unaffected in Alk2/Gata5-Cre mutants at E11. H&E-stained sagittal sections through OFT
cushions (A, B) and AV cushions (C, D) show plentiful mesenchymal cells in controls (A, C) and Alk2/Gata5-Cre mutants (B, D). Black arrows in A–D
point to cushion mesenchyme. E–F, RT-PCR analysis of mRNAs from OFT (E) and AVJ (F) tissues at E11.5. C Alk2
FXWT/Gata5-Cre
2 control; M Alk2
FXKO/
Gata5-Cre
+ mutant. The shorter amplification product (Alk2
KO) predominant in mutant tissues confirms an efficient Cre-induced recombination. G,
Gata5-Cre-induced recombination leads to reduction in Smad 1/5/8 phosphorylation in mutant (M) relative to control (C) E12.5 OFT tissue protein
lysates analyzed by immunoblotting. H, Bar graph shows relative quantification of phospho-Smad1/5/8 in control (blue) and mutant (red) OFT tissues
at E12.5 (normalized to b-actin; n=3). Error bars, SEM; *p,0.05.
doi:10.1371/journal.pone.0035539.g002
Table 1. BAV and VSD in Alk2/Gata5-Cre mutants.
Stage Genotype Total
BAV
(percentage)
VSD
(percentage)
E14 Alk2
KOFX/Gata5-Cre+ 9 7 (78%) 7 (78%)
E17–E18 Alk2
KOFX/Gata5-Cre+ 6 5 (83%) 2 (33%)
doi:10.1371/journal.pone.0035539.t001
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early as E11.5 [7]. To examine whether abnormal expression of
these genes was part of the mechanism underlying our model we
therefore compared the mRNA expression patterns of using ISH
(Notch1, Gata5) or immunofluorescence (Nos3) at E11, and at
several levels of the OFT to ensure that regional defects in
expression, perhaps associated specifically with the future
intercalated cushion development, were not missed. In both
control and mutant sections, the expression of all three genes was
detected in AV and OFT endocardium, and in a somewhat
similar, non-uniform, way both along the length of the OFT and
around its lumen (Figure 7). Notch1 and Nos3 were detected in
most if not all OFT endocardial cells but staining was stronger (or
appeared sooner) more distally, and in lateral areas between
adjacent cushions and where the intercalated cushions were
developing. Gata5 endocardial expression was harder to detect but
present in endocardium adjacent to rather than over the two main
cushions at distal and mid-levels, the same areas in which Notch1
and Nos3 staining was also higher (Figure 7G–L). They were all
detected in endocardium over the proximal cushion as it extends
into the ventricle (Figure 7M–R). We also examined expression of
Notch1 target genes Hey1 and Hey2 (Figure S2). In OFT
endocardial cells, Hey1 expression was highly restricted, principally
to the endocardium between the main cushions, similar to that of
Gata5 (see above). Hey2 expression was detected in most OFT
endocardial cells, in a pattern very similar to that of Notch1.I nA V
Figure 3. Gata5-Cre-induced deletion of Alk2 function leads to defective development of aortic valves. A–F: Histological comparison of
representative control (A, C, E) and mutant (B, D, F) aortic valves at E14; approximately transverse sections of the same valves at three levels. A, B:
lower magnification at the level of coronary orifices (red arrow; coronary vessel: red arrowhead), where formed, distal to aortic valve leaflets showing
normal development and relationship of aortic-side structures relative to pulmonary valve. All three control aortic leaflet cushions show evidenceo f
excavation forming sinuses (green *): left (L) in panel C, right (R) and non-coronary (N) in panel E. N cushion occupies a similar segment of the
circumference (black lines) as each of R and L (in E). In mutant valve, L (in D) and R (in F) leaflet cushions show normal excavation. Cushion ‘R’,
although in the same position as N in control, is continuous with tissue R (panel D), not simply apposed as in control (in C). Nearer the base of the
leaflet cushions (in E, F), mutant R is larger than control R. A small cushion (‘N’) is present between L and ‘R’ (in D, F), but shows no evidence of
excavation and occupies a much smaller segment of the circumference (black lines in F) than N in control, so the valve is functionally bicuspid
(bifoliate), with two excavating leaflet cushions, L and R/‘R’, apposing one another distally (in D). G–R: Histological comparison of representative
control (A, J, M, P) and two functionally bicuspid mutant (H, K, N, Q and I, L, O, R) aortic valves at E17; approximately transverse sections of the same
valves at four levels. G-I, at the level of coronary orifices showing their consistent position above right and left coronary leaflets, and consistent
positioning of the leaflets in relation to adjacent tissues, in control and mutants. All three control aortic leaflet walls lie adjacent to well-developed
sinuses (green *) left (L) in panel J, right (R) and non-coronary (N) in panel M. N leaflet occupies a similar segment of the circumference (black lines) as
R and L (in J). Two examples of functionally bicuspid mutant valves are shown to illustrate key details of their morphology at this stage. The example
in H, K, N, Q has features consistent with a fusion of R and N leaflets. Distally (K), only two leaflets, R and L, appose each other, with no small leaflet
between them in the non-coronary position, each occupying about half the circumference (black lines). More proximally, the sinus of the R leaflet is
divided into two (green *) by a raphe (black arrowhead) in N, but the leaflet does not then divide into two separate bases (arrowhead, Q). Distally the
mutant valve shown in I, L, O, R also consists of two leaflets (in panel L; as R and ‘R’ are joined more proximally) that are not separated by a small
cushion, but more proximally, one (‘N’) present. An area representing an interleaflet triangle (red curved line) can be identified between L and R
leaflets in control (in M) and mutant (K, L) valves, and between L and N (control, in M) but the bases of the R and N leaflets even in control remain
adjacent (in P, red X, black arrow) though not continuous (unlike Q). S,T: 6 month old adult control aortic valve with normal left (L) right (R) and non-
coronary (N) leaflets (black arrows) and three sinuses (green*), and partially dissected functionally bicuspid aortic valve in Alk2/Gata5-Cre mutant,
demonstrating two leaflets (black arrows) which appose only with each other across the entire lumen, and two sinuses (green *). Aor Tr, Aortic trunk;
Pul Val, Pulmonary Valve.
doi:10.1371/journal.pone.0035539.g003
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small subset of Notch1-positive cells, Hey1 being almost completely
undetected. Again we could demonstrate no consistent differences
in expression between control and mutant tissues.
Levels of mesenchymal staining present in sections probed for
these genes were too low to interpret and compare (Figure 7,
Figure S2 and data not shown). Nos3 expression was not detected
above background in mesenchyme cells by immunofluorescence.
In non-endocardial cells, Gata5 and Hey1 expressions were
detected in overlapping domains of second heart field cells of
the distal OFT, Hey1 expression in atrial appendage myocardium
and a regional population of epicardial cells, Hey2 in ventricular
wall myocardium and Gata5 weakly in AV and some OFT
myocardium (Figure 7, Figure S2 and data not shown).
From this detailed examination of expression of genes
previously associated with BAV, we conclude that although there
were regional differences in gene expression within the OFT
consistent with a role for these genes in the development of the
Figure 4. Ventricular septal defect and abnormal right atrioventricular valve leaflets in Alk2/Gata5-Cre mutants. H&E-stained sections
of control (A–C) and Alk2/Gata5-Cre mutant (D–F) at three different levels showing perimembranous VSD in mutant (black arrow in E) but not control.
Right (G–J) and left (K–N) atrioventricular valves from control (G, H, K, L) and Alk2/Gata5-Cre mutant (I, J, M, N) samples. Representative
immunostained sections from two levels from each heart are shown: periostin (green), MF20 (red). Postero-inferior leaflet (G–J) shorter with less
periostin-positive tissue (green) in mutant (I, J) than control (G, H) (arrows) and more myocardium (red: arrowheads). Control (K, L) and mutant (M, N)
left AV valve leaflets do not differ (arrows, arrowheads). AVJ posterior side of atrioventricular junction; IVS muscular part of ventricular septum; LA, left
atrium; LV, left ventricle; LVO, outlet part of LV leading to aortic valve; RA, right atrium; RV, right ventricle.
doi:10.1371/journal.pone.0035539.g004
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between control and mutant samples. Despite the similarity of
bicuspid phenotype (R-N fusion) with that reported in Gata5 and
Nos3 mutants, these results provide no evidence that Alk2-
mediated signaling leads to mis-expression of genes known to be
associated with BAV, suggesting that the pathogenetic mechanism
leading to BAV in these Alk2 mutants is novel or acting
downstream of these genes.
Functional defects in adult Alk2/Gata5-Cre mutants
As mentioned above, 45% of mutant mice survived to
adulthood. We analyzed aortic valve function in 22 of these mice
at 3–18 months using echocardiography (Figure 8A–C). Hemo-
dynamic evaluation of Alk2/Gata5-Cre mutant and age/sex-
matched control mice (see methods) demonstrated an increased
velocity gradient across the aortic valve of 6 mutant mice
consistent with aortic stenosis (Figure 8D). In addition, two of
the six mice with stenosis displayed regurgitation indicative of
aortic insufficiency (Figure 8B). Subsequently, the mice were
euthanized and aortic valve tissues further analyzed grossly, then
histologically (as also reported above) or for gene expression by
real-time quantitative RT-PCR (below). Histological analyses
showed that mutant valve leaflets were irregularly thickened and
hypercellular when compared to corresponding controls
(Figure 8E–F) typical of stenotic valve leaflets, though elevated
cell proliferation was not detected (Figure S3B). Such features
might be expected at least to compromise flexibility, resulting in
stenosis, as well as efficient apposition, resulting in insufficiency.
We harvested aortic valve tissue from three functionally
abnormal Alk2 mutants and three functionally normal age/sex-
matched controls and analyzed them for expression of selected
genes associated with osteogenic differentiation or inflammation
implicated in human valve disease [36]. The results imply that
inflammatory pathways were not involved in the pathogenesis as
there were no genotype-consistent changes in Alox5 or Cd68
expression between mutant and control tissues (Figure S3). In
contrast, mutant tissues showed a clear tendency for higher
osteopontin (Spp1, p=0.054) and lower Sox9 (p=0.057) expression
when compared to corresponding control tissues (Figure 8I).
Moreover, the Spp1 and Sox9 expression levels were inversely
related to one another (Figure S3A), consistent with the recent
model proposed by Peacock et al [37]. Since reduced levels of Sox9
have been shown to be causally related to valve ossification [37],
the observed differences are consistent with a model in which
affected valve tissues in Alk2 mutants with aortic stenosis and
insufficiency display pro-osteogenic changes. However, expression
of the key osteogenic transcription factor Runx2 was consistently
lower in mutant valve tissues than in controls, and valve
calcification was not detected by von Kossa or Alizarin Red
staining (Figure 8G–H). We also analyzed activation of Bmp
Smads (Smads1/5/8), Erk1/2 and p38 Mapk using Western
blotting and probing with phospho-specific antibodies. Phosphor-
ylation levels of Bmp Smads were very low and did not show
detectable differences between mutants and controls. In contrast,
the samples harvested from Alk2 mutants that showed both stenosis
and insufficiency showed consistent, robust increase in Erk1/2
phosphorylation, and a less pronounced increase in p38-Mapk
phosphorylation (Figure 8J–K). Prolonged Erk1/2 activation has
been shown to lead to calcification in valve interstitial cell cultures
in vitro [38]. Although the limited sample number (n=2) does not
allow us to establish statistical significance, these experiments
suggest that the increase in Erk1/2 phosphorylation we observe
contributes to pro-osteogenic expression pattern shown in
Figure 8I.
Figure 5. Less proliferation in endocardial cushion mesenchyme in Alk2/Gata5-Cre mutants. Representative images of anti-BrdU
immunostaining (green-yellow) of control (A, C, E, G) and Alk2/Gata5-Cre mutant (B, D, F, H) sagittal sections at E11 (A, B, E, F) and E12 (C, D, G, H). A–
D, OFT cushions; E–H, AV cushions. Mutant OFT cushion shows patchy incidence of BrdU- labeled nuclei (e.g., less in myocardium-adjacent region
ringed by white ellipse). Bar graphs (I, J) illustrate differences in proportion of BrdU-labeled nuclei in the OFT (I) and AVJ (J) mesenchyme at E11 (left
columns) and E12 (right columns) (n=3) OFT, Outflow tract cushions; AV, atrioventricular cushions; C, control; M, mutant; Error bars, SEM; *p,0.05.
doi:10.1371/journal.pone.0035539.g005
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Abnormal Alk2 function has been implicated in human cardiac
disease [29,30]. However, our current knowledge about the role of
Alk2 in cardiac development is limited to endocardial EMT and
neural crest cell migration [26,39,40], and it is not known which
Alk2-mediated processes fail in human patients that show disease-
causing mutations in the Alk2 gene. Since EMT fails in Alk2/Tie2-
Cre mutants,efficient analysis ofa laterrole forAlk2 inendocardium
or its derivatives in post-EMT septum and valve development in
isolationisnot possibleusingthismodel.Similarly,inAlk2/Wnt1-Cre
mutants, recombination in neural crest cells occurs very early and
affects not only the initial distribution of these cells in the OFT but
also causes malformations in adjacent structures that could affect
valve morphogenesis indirectly [39]. To overcome these limitations,
we used the Gata5-Cre transgenic mouse line. This was originally
designed as an epicardium-specific driver but this and our earlier
studies have shown that Alk2does not play a detectable essentialrole
in the epicardium (Figure S1) or working myocardium [26].
Recombination inendocardium commences afterthemain phase of
Alk2-dependent EMT, and, in contrast with AV events, no defects
in OFT septation or arterial valve development were detected in
Alk2/Tie2-Cre mutants [26]. In the present study we show that
Gata5-Cre induces efficient recombination in all cushion mesen-
chyme soon after EMT or migration. Using this driver line, we
found that, following abrogation of Alk2 in the endocardial cushion
Figure 6. Sox9 and Tbx20 expression and less cleaved versican and tenascin-C in endocardial cushions and valve leaflets in controls
and Alk2/Gata5-Cre mutants. In situ hybridization for Sox9 (A–D) and Tbx20 (E–J) on sagittal (A–H) and transverse (I, J) sections of E11 control and
Alk2/Gata5-Cre mutant hearts. Prominent expression of both genes in atrioventricular (AVJ) and outflow tract (OFT) cushions in both control and
mutant samples. Stronger staining detectable in certain regions of endocardium (Tbx20: red arrows in I, J) in equivalent areas of both control and
mutant. Although staining for both Sox9 and Tbx20 in cushion mesenchyme also varied between adjacent cells (illustrated in J: short arrow lower vs
double arrowhead higher), mutant but not control had groups of adjacent groups cells of lower (such as red asterisk in H) and higher (red ellipse)
Tbx20 signal. Immunostaining for total versican on sagittal E11 control (K) and Alk2/Gata5-Cre mutant (L) sections (green: versican; red: MF20). M–P,
immunostaining for cleaved versican using anti-DPEAAE antibody on control (M,O) and Alk2/Gata5-Cre (N,P) sections. M–N, sagittal sections at E11;
O–P, transverse sections at E14; green: cleaved versican; red: MF20. Staining in control AVJ mesenchyme (arrow in M,O) more extensive than mutant
(arrowhead in N,P), though both similar in OFT. Immunostaining for tenascin-C on control (Q,S) and Alk2/Gata5-Cre mutant (R,T) sections; Q,R, sagittal
sections at E11; S,T, transverse sections at E14. Green, tenascin-C (TNC); red, MF20. Staining in control mesenchyme (arrow) more extensive than
mutant (arrowhead). AVJ, atrioventricular cushions; OFT, outflow tract cushions; IVS, ventricular septum; myo, OFT myocardium; RV, right ventricle.
doi:10.1371/journal.pone.0035539.g006
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functional BAVs developed.
In a recent detailed analysis of BAV development [11], two
morphologically and etiologically different rodent models were
studied: the mouse model lacking Nos3, where BAVs results from
right and non-coronary (R-N) leaflet precursor fusion present at or
before OFT septation occurs, and a well-established hamster
model where right-left coronary (R-L) leaflet fusions are associated
with abnormal OFT septation morphology. The R-N and R-L
BAV phenotypes are the two more common in humans, and have
different clinical implications. In pediatric patients, R-N BAVs are
more likely to progress rapidly to aortic insufficiency and stenosis,
while those with R-L BAVs develop more rapid aortic wall
regeneration [3]. Our analysis of the Alk2/Gata5-Cre mutant aortic
valve during its embryonic morphogenesis shows no evidence of
BAV formed by R-L leaflet fusion, but a spectrum of defects
including fusion of R-N leaflet precursors, and functional bicuspid
valve composed of separate right and left leaflets each adjacent to a
coronary orifice, and only a very small, poorly formed leaflet in the
non-coronary position. Genetic mutants surviving to adulthood
Figure 7. Regional patterns of BAV-associated gene expression do not differ between control and Alk2/Gata5-Cre mutant outflow
tracts. Sections transverse to distal (A–F), mid (G–L) and proximal (M–R) outflow tracts of control (A–C; G–I, M–O) and mutant (D–F; J–L; P–R) embryos
showing expression patterns of Nos3 (Immunostaining: Nos3, pink; myocardium, blue-purple; nuclei, yellow; images color-inverted so that signal in
single layer of endocardium is visible), (A, D, G, J, M, P); Gata5 (ISH: B, E, H, K, N, Q) and Notch1 (ISH: C, F, I, L, O, R). Staining for Nos3 and Notch1
present in virtually all endocardial cells in the OFT; Gata5 (e.g., arrow heads) detected above background in endocardium lateral to rather than over
the two main cushions (septal, parietal: *) where Notch1 and Nos3 also more strongly expressed (arrows). Non-coronary leaflet develops from the
intercalated cushion on the left in these images, right coronary from the adjacent part of the parietal cushion (* in the more anterior position). Gata5
also detected in second heart field (SHF) cells/most distal OFT wall. OFT, myo: outflow tract myocardium; OFT end, OFT endocardium; AV myo,
atrioventricular myocardium; AVJ, atrioventricular cushion; RV, right ventricle; LV, left ventricle.
doi:10.1371/journal.pone.0035539.g007
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PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e35539Figure 8. Aortic stenosis and insufficiency in Alk2/Gata5-Cre mutants. Echocardiography of a control (A), an Alk2/Gata5-Cre mutant with aortic
stenosis and insufficiency (B) and an Alk2/Gata5-Cre mutant with aortic stenosis (C). A bar graph (D) depicts the two-fold difference in aortic velocity
index between controls (C) and stenotic mutants (M) (n=6). Aortic valve leaflets (arrows) of stenotic Alk2/Gata5-Cre mutant thickened and
hypercellular (F) when compared to those of age- and sex-matched control (E) (Von Kossa-stained sections with nuclear red counterstain). Dark
patches are endogenous melanin, not evidence of calcification: Alizarin Red staining on sister section to (F) (pre-staining, G; post staining H) shows
dark patches (e.g., green arrowheads) match precisely and no bright red positive stain for calcium. I, Relative real-time RT-PCR quantification of Sox9,
Runx2 and Spp1 (osteopontin) in isolated valve leaflets of controls and Alk2/Gata5-Cre mutants with aortic stenosis and insufficiency (n=2). J, Up-
regulation of phospho-Erk1/2 and phospho–p38 in samples with aortic stenosis and insufficiency (n=2). Bar graph (K) depicts relative quantification
of phospho-Erk1/2 and phospho-p38 between controls and Alk2/Gata5-Cre mutants shown in J (n=2). Error bars, SEM; *p,0.05.
doi:10.1371/journal.pone.0035539.g008
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controls. In investigating the mechanism underlying these
phenotypes, we looked for a relationship with the Nos3 (and
related Gata5) R-N fusion models. We could find no difference in
expression of Nos3 or Gata5 immediately prior to the stage at which
morphological abnormalities were apparent in these models,
suggesting that Alk2 lies downstream or a different pathway is
involved. Although the category of BAV resulting from altered
expression of Notch1 signaling has not been reported, we also
established that expression of Notch1 itself was not altered prior to
cushion maturation. Notch signaling is also implicated in
preventing calcification, which is frequently associated with
thickened or mechanically compromised valves with stenosis in
humans, but no evidence of calcification was found in our adult
mutant mice with stenosis suggesting that either Notch signaling is
not compromised, or other aspects of the abnormal phenotype of
the valve cells were simultaneously protective. Some pro-
osteogenic differences (lower Sox9 and higher Spp1 expression
and higher Erk1/2 phosphorylation in mutant valve leaflets) were
detected, but not others: Runx2 expression and Bmp Smad
phosphorylation were not elevated. Calcification in mouse valves
with compromised Notch1 signaling results only after a further
perturbation (high cholesterol diet) [41] and involves inflammatory
cells in which abnormal Notch signaling is also implicated as
responsible for their contributing to the calcified phenotype as well
as valve interstitial cells. We found no evidence of higher expression
of two markers of inflammation in stenotic adult Alk2/Gata5-Cre
mutant aortic valves, suggesting that inflammation was not causalto
the stenosis. Together with absence of calcification, reduced Notch
signaling as a result of Alk2 deficiency in the valves of adult Gata5-
Cre/Alk2 mutants valves is also unlikely.
Further to establishing the mechanism underlying the BAV
phenotype present by E14, we examined other aspects of cell
behavior in the precursor tissues. Alk2/Gata5-Cre mutant cushions
contained plenty of mesenchymal cells, and cushion organization
closely resembled that in controls soon after recombination.
However, we detected a 40% reduction in mesenchymal cell
proliferation rate at E11 and E12, greater than the 20–25%
reported for Gata5-deficient cushion mesenchyme [7], and reduced
phosphorylation of Bmp Smads in OFT tissues at E12.
Transcription factors Sox9 and Tbx20 have been implicated in
promoting proliferation over differentiation in cushion mesen-
chyme and we have found some evidence that our mutant
cushions contain patches of mesenchyme with reduced Tbx20
expression. Some altered expression of cleaved versican and
tenascin-C were also found, but there was no simple correlation
with later morphological differences between control and mutants.
Levels of cleaved versican were reduced in AV cushions but an
increase in cellularity was not observed. Subtle abnormalities in
Alk2/Gata5-Cre right atrioventicular but not left atrioventricular
AV valve leaflets were detected at E18 but the tenascin-C
expression adjacent to both valves was altered in mutants. AV and
OFT septation, which might be expected to be compromised by a
reduction in mesenchyme cell number, still occurred, and the
incidence of VSDs was reduced by more than 50% between E14
and E18, suggesting that abnormalities created by Alk2 signaling
deficiency might be rescued or ameliorated over time.
Aortic leaflets of Alk2/Gata5-Cre mutants did not appear of
abnormal thickness or cellularity at a late embryonic stage. Leaflets
from mutant adult valves with stenosis were abnormally thickened,
incommonwith diseased humanvalves(data not shown), but we did
not detect evidence of higher cell proliferation than that in control
valve tissues after diagnosis, so the timing and mechanisms
underlying this process remain to be determined, and may be
secondary to the morphology rather than the altered Alk2 function.
Even in aortic valves with three leaflets, there is a correlation
between developing valve disease and the deviation of leaflet size
away from equality in humans. The abnormal mechanical stresses
onvalveleafletsinthesesettingscouldleadtoabnormalorganization
and repair of valve components [18], even without the direct effects
of an abnormal valve cell genotype being taken into account.
Detailed studies by others [7,11] have started to provide
information about the morphological events underlying the
development of BAV in rodents during embryonic development.
Our work here on the Alk2/Gata5-Cre model also reveals a novel
morphological feature not reported by others. Rather than only
two leaflet cushions, or a simple R-N, or fusing intermediate
phenotype, being present by E14, and at E17, our evidence
demonstrates that in most cases a small third cushion in the non-
coronary position was still present in mutant aortic valves,
although the other two leaflets appose one another across the
lumen and are performing the valvar function at this time. The
presence of such a structure may further compromise function
after birth if it maintains its relative size by impeding apposition of
the other valve leaflets. It remains to be determined why this
structure and not the pulmonary equivalent, is altered. Both are
formed from intercalated cushions in the OFT, and, as our
detailed ISH analysis here shows for the first time, expression of
BAV-implicated genes Nos3, Gata5, Hey1 and Notch1 was highest in
the OFT endocardium in ‘lateral’ positions that include where the
intercalated cushions develop immediately before morphological
abnormalities are first detectable in these models. All OFT
cushions contain mesenchymal cells formed by EMT, but, unlike
the larger (parietal and septal) cushions, intercalated cushion
mesenchyme includes a molecularly distinct population that may
be of pharyngeal mesoderm origin (Robert Anderson, personal
communication (Sizarov et al 2012 in press)), as well as far fewer
neural crest cells [11]. However, as the intercalated cushions lie on
opposite sides of the OFT lumen, they are also adjacent to
myocardial populations that differ in their molecular identity [42],
and, as the aortic and pulmonary valve precursors are differently
positioned within the OFT relative to other structures, they may
experience different flow conditions even before septation [43].
Experimentally altered flow patterns can result in abnormal
cushion formation in earlier embryos [44] and in valve leaflets [45]
and secondary shear stress or flow-related mechanisms might
contribute to the phenotypes identified in animal models of BAV.
Nos3 expression is regulated by flow [46,47], which affects
endothelial motility and EMT [48]. Moreover, Fernandez et al
[21] suggest a mechanism whereby Nos3 deficiency results in
abnormalities in endocardial generation of mesenchyme (EMT),
which leads to a failure to form separate precursor cushions for the
right and non-coronary leaflets. Notch1 signaling is also implicated
in EMT and this might contribute to its role in BAV in humans. It
is important to note that in none of the descriptions of animal BAV
models [7,49](this paper) is there definitive evidence of fusion
between separate, fully formed, excavated leaflets, and that
therefore the term ‘fused’ or ‘fusion’ used when defining BAV
morphology should not be presumed to imply such a process.
Instead the BAVs in both Nos3 (and perhaps Gata5) –deficient R-N
mice and R-L hamster phenotypes originate as a lack of failure to
develop separate leaflets through the failure to develop normal
separate leaflet cushions at a much earlier stage. Nevertheless,
further remodeling of mature valve leaflets through flow-mediated
or other mechanisms, and early death, might be expected to
contribute to the variable penetrance of BAV and other
phenotypes in postnatal animals in this and other models
(Nos3
2/2: 5/12 BAV in adults [6]; Gata5-/- 25% BAV in adults,
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background, up to 8 times that of controls [5]). Inadequate
function of the more abnormal aortic valves at birth, and reduced
cardiac efficiency where ventricular septation had not occurred are
obvious candidates to account for the 55% death rate amongst
early postnatal Alk2/Gata5-Cre mutants and thus reduce the
penetrance of BAV greatly from its late embryonic rate.
The absence of OFT septal defects and the reduction in
penetrance of VSD during prenatal development ventricular
septation are consistent with roles for Alk2 in septal and valvar
maturation that are partially redundant or subject to genetic
modifiers that affect the severity of the phenotype, or involve
processes in which there is a degree of plasticity in timing.
Whether always three leaflet, or the result of postnatal ‘recovery’
from a prenatal functional BAV phenotype, the incidence of
stenosis argues that three leaflet aortic valves in Alk2 mutants still
remain susceptible to stenosis and insufficiency.
Materials and Methods
Mice
Mice carrying the conditional Alk2-flox allele (Alk2
FX) and Gata5-
Cre transgenic mice were used and genotyped as previously
described [31,39]. Tbx18-Cre mice were kindly provided by Dr. S
Evans [50] and were genotyped for the presence of Cre by PCR
(oligo sequences; Cre-F, 59-cgttttctgagcatacctgga-39; Cre-R, 59-
attctcccaccgtcagtacg-39). Timed matings between male mice that
were heterozygous for the Alk2 knockout allele (Alk2
WTKO) carrying
a heterozygous Gata5-Cre (or Tbx18-Cre) transgene, and female
mice homozygous for the Alk2-flox allele (Alk2
FXFX) were used to
obtain Alk2
FXKO/Gata5-Cre
+ tissue-specific mutant embryos (herein
called Alk2/Gata5-Cre). As controls, we used Alk2
FXWT/Gata5-Cre
2
littermates, which have two functional Alk2 alleles.
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
experiments described in this study were specifically approved by
the University Committee on Use and Care of Animals of the
University of Michigan-Ann Arbor (Protocol Number: #09944).
R26R lineage tracing
For lineage tracing experiments, timed matings were set up
between Alk2
WTKO/Gata5-Cre
+ males and Alk2
FXFX/R26R
lacz/lacz
females as previously described [51]. The embryos were harvested
(E10-E11) and stained for the presence of b-galactosidase activity as
described [52].
Histology, immunohistochemistry, apoptosis and BrdU
incorporation assays
Embryos were fixed in 4% paraformaldehyde for 12–18 hours
at 4uC, dehydrated and embedded in Leica Histowax according to
standard procedures. After embedding, sections were cut at 5–
7 mm. Histological analysis was performed on sections stained with
hematoxylin and eosin according to standard procedures. For
immunohistochemistry, citrate antigen retrieval was performed
where necessary (and before anti-BrdU antibody use, where
combined staining was performed). Primary antibodies (listed
below) were detected using either Alexafluor-594 or Alexafluor-
488 secondary antibodies (Invitrogen) on sections mounted in
Vectashield containing DAPI or propidium iodide nuclear
counterstains (Vector Labs Inc). Primary antibodies to the
following used were: periostin (Abcam ab14041), versican
(Chemicon AB1033), cleaved versican (DPEAAE) (Thermoscien-
tific PAI-86354), MF20 (DSHB), Nos3 (eNos) (Thermoscientific
RB9279-P) and WT1(Santa Cruz Biotechnology sc-192). Apo-
ptotic cells were detected using the ‘Dead End’ TUNEL assay kit
(Promega) following manufacturer’s instructions. For cell prolifer-
ation analyses i.p. injections of cell proliferation labeling reagent
(RPN201, Amersham/GE Healthcare) were performed. BrdU-
labelled cells were detected on sectioned wax-embedded tissues
using anti-BrdU antibody (RPN202, Amersham/GE Healthcare)
according to manufacturer’s instructions. Fluorescent images were
viewed on an Olympus BX51 microscope and documented using
an Olympus DP71 camera. Adobe Photoshop CS4 was used to
invert the image colors to enable the results to be visible. Each
assay was repeated at least once; see figure texts for details.
In situ hybridization (ISH)
For RNA in situ hybridization, embryos were fixed in 4%
buffered paraformaldehyde for 12–18 hours, dehydrated and
either stored in 95% ethanol at 220uC until needed or processed
for embedding in Leica Histowax or BlueRibbon embedding
medium. In situ hybridization was performed [53] on 10 mm
sections using non radio-active DIG-labeled RNA probes made
according to manufacturer’s instructions (Roche Applied Science).
Each analysis was performed on 2–3 independent samples per
genotype. Probes for Sox9, Tbx20, Notch1 and Hey2 were made
from templates kindly provided by Nobby Kamiya [54], Richard
Harvey [55] and Irma Thesleff [56], respectively. Probes for Alk2
(nts 814–1414 and nts1281–2024 of NM_001110204) Gata5 (nts
1460–2061 of NM_008093) and Hey1 (nts 205–1105 of
NM_010423) were made from cloned templates containing
PCR-amplified sequences from total mouse cDNA. Results were
viewed on an Olympus BX51 or Leica MZ95 microscope and
documented using an Olympus DP71 camera and software.
Real-time Quantitative PCR
Total RNAs were isolated from individual aortic valves
(trimmed to include mainly leaflets) placed in RLT buffer (Qiagen)
and DTT using the RNeasy microkit (Qiagen), and used
immediately to synthesize cDNA using Omniscript reverse-
transcriptase (Qiagen) and random priming according to manu-
facturer’s instructions. cDNA aliquots (one tenth each total cDNA
prep) were then pre-amplified for 10 cycles using Taqman
PreAmp Mastermix (Applied Biosystems) and the same batch of
diluted mix of primers used for subsequent quantitative PCR
assays, and the resulting products diluted, all according to
manufacturer’s instructions. b-actin (Actb) primers were included
in the pre-amplification mix. Real-time qPCR analyses were
performed using Universal ProbeLibrary-based assays (Roche
Applied Science) with gene-specific primer sequences generated by
the manufacturer’s online site (https://www.roche-applied-
science.com/sis/rtpcr/upl/index.jsp?id=UP030000). Each 30 ml
reaction included 2 ml of sample as prepared above, 1 ml each
forward and reverse primer (stock 20 mM), 0.5 ml Probe and 15 ml
Taqman Universal PCR Master Mix (Applied Biosystems). 45-
cycle assays were performed using the ABI 7300 PCR and
Detection System (Applied Biosystems) and analysed using 7500
System v1.2.2 software. b ˜actin was used to standardize relative
quantities. Results with Cts outside 15–30 cycles were excluded.
cDNAs from aortic valve tissue from three different control and
mutant mice were analyzed simultaneously.
Immunoblotting
For Western blots, tissues were lysed in 26 Laemmli sample
buffer [57], heated at 80uC for 10 minutes, and quantified by
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protein per lane) were loaded onto NuPaGE 4–12% Bis-Tris gels
(Invitrogen) and run at 200 V for 50 minutes. Proteins were
transferred onto nitrocellulose filters using an iBlot dry blotting
system (Invitrogen). For immunodetection, filters were blocked
with 5% milk for 1 hour and incubated with primary antibodies
for 12–16 hours at +4uC in 2%milk. Primary antibodies to the
following antigens were used (all Cell Signaling Technology unless
otherwise stated) phospho-Smad 1,5,8 (9511), phospho-Erk1/2
(4376), Erk1/2 (4695), phospho-p38Mapk (4511), p38Mapk (Santa
Cruz Biotechnology sc-728), b-actin (Sigma A1978). The filters
were washed in TBST, incubated for 30 mins with HRP-labeled
secondary antibodies washed again in TBST and incubated for
5 minutes in Immobilon HRP Substrate (Millipore). Detection
and quantification was accomplished by using the BioSpectrum
AC imaging system (UVP).
Echocardiography
Induction of anesthesia was performed in an enclosed container
filled with 4% isoflurane. After induction, the mice were placed on
a warming pad to maintain body temperature. 1–1.5% isoflurane
was supplied via a nose cone to maintain a surgical plane of
anesthesia. The hair was removed from the upper abdominal and
thoracic area with depilatory cream. ECG was monitored via non-
invasive resting ECG electrodes. Transthoracic echocardiography
was performed in the supine or left lateral position. Two-
dimensional, M-mode, Doppler and tissue Doppler echocardio-
graphic images were recorded using a Visual Sonics’ Vevo 770
high resolution in vivo micro-imaging system. LV ejection fraction
was measured from the two-dimensional long axis view. Systolic
and diastolic dimensions and wall thickness were measured by M-
mode in the parasternal short axis view at the level of the papillary
muscles. Fractional shortening and ejection fraction were also
calculated from the M-mode parasternal short axis view. Diastolic
function was assessed by conventional pulsed-wave spectral
Doppler analysis of mitral valve inflow patterns (early [E] and
late [A] filling waves). Doppler tissue imaging (DTI) was used to
measure the early (Ea) diastolic tissue velocities of the septal and
lateral annuluses of the mitral valve in the apical 4-chamber view.
Echo was performed on 3 month-old (3 male, 3 female), 7.5
month-old (4 male, 4 female) and 13 month or older (4 male, 4
female) Alk2/Gata5-Cre mutants, along with male and female
control animals of the same ages.
Histological detection of calcification
Von Kossa staining with nuclear red counterstaining was
performed on rehydrated 7 mm formaldehyde-fixed tissue sections
using the Diagnostic Biosystems kit (Pleasanton CA) according to
manufacturer’s instructions. Alzarin Red staining was performed
on sister sections with freshly prepared alizarin red using a
standard protocol. Resulting sections were viewed on an Olympus
BX51 microscope and documented using an Olympus DP71
camera and software.
Statistical analysis
Statistical analysis was done by Mann-Whitney U test. P
values,0.05 were considered significant. Error bars represent
SEM in all bar graphs.
Supporting Information
Figure S1 No detectable cardiac defects in epicardium-
specific Alk2 mutants. Coronary vasculature smooth muscle
and cardiac fibroblast cells are both epicardium-derived. R26R-
driven bgal staining (blue) shows that abrogation of Alk2 function
in epicardial cells using the Tbx18-Cre driver line did not cause
detectable defects in the smooth muscle cell layer surrounding
coronary arteries (E18: white arrows in A, B) or in generation and
migration of epicardially derived WT1-positive cells (white
arrowheads) into the ventricular walls (C, D) (E13: immunostain-
ing for WT1, green; for MF20, red). A and C, controls; B and D,
Alk2/Gata5-Cre mutants.
(TIF)
Figure S2 No difference in regional patterns of Notch1
target genes Hey1 and Hey2 between control and Alk2/
Gata5-Cre mutant outflow tracts. ISH performed on sections
transverse to distal (A–D), mid (E–H) and proximal (I–L) outflow
tract of control (A, B, E, F, I, J) and mutant (C, D, G, H, K, L)
embryos showing expression patterns (blue) of Hey1 (A, C, E, G, I,
K) and Hey2 (ISH: B, D, F, H, J, L). Hey1 expression in OFT
endocardium (arrow head) restricted to cells lateral to but not over
the two main OFT cushions (parietal, septal *). ISH staining for
Hey1 on sagittal sections (distal to the left) of control (I9) and
mutant (K9) also not above background in mesenchymal cells of
the proximal OFT cushions (Prox OFT). Hey2 detected in most
OFT endocardial cells but stronger in areas lateral to the main
OFT cushions (arrows). Non-coronary leaflet will develop from the
intercalated cushion on the left side in these images. Hey1 also
detected in atrial appendage myocardium (A Myo) and epicardi-
um (green arrow). Hey2 also detected in ventricular wall
myocardium (V Myo).
(TIF)
Figure S3 Expression findings in valve leaflets of Alk2/
Gata5-Cre mutants with aortic stenosis and insufficien-
cy. A, Scatter plot demonstrates inverse relationship between Spp1
and Sox9 expression in aortic valve leaflets of stenotic Alk2/Gata5-
Cre mutants measured by real-time RT-PCR. B, Bar graph
illustrates no difference in relative expression of inflammation
markers Alox5 and Cd68, and of proliferation marker Pcna,i n
stenotic mutant (red) and normal control (blue) aortic valve leaflets
measured by real-time RT-PCR quantification (n=3). Error bars,
SEM.
(TIF)
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